I am/have/had
I am looking for
Advanced Filters
Found 2 clinical trials
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
The names of the study interventions involved in this study are: Sacituzumab govitecan (IMMU-132) Pembrolizumab (Keytruda; MK-3475)
liver metastasis
immunohistochemistry
corticosteroids
tubal ligation
keytruda
- 8 views
- 19 Feb, 2024
A Study of Sacituzumab Govitecan (IMMU-132) in Endometrial Carcinoma
This is a non-randomized Phase 2 study of sacituzumab govitecan (IMMU-132) in subjects with persistent or recurrent endometrial carcinoma.
liver metastasis
ascites
renal function
carcinoma
pleural effusions
- 0 views
- 19 Feb, 2024